Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EVER
EVER logo

EVER Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy EverQuote Inc (EVER) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
15.190
1 Day change
-4.47%
52 Week Range
28.730
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

EverQuote Inc (EVER) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong Q4 financial performance, positive hedge fund activity, and compelling analyst ratings outweigh the lack of recent news and neutral technical indicators. The asset offers a solid growth opportunity for long-term investment.

Technical Analysis

The technical indicators are mixed. The MACD is positive and expanding, suggesting bullish momentum, but the RSI is neutral at 50.274, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels are at Pivot: 15.834, R1: 16.461, and S1: 15.208. The stock is trading near its pivot point, indicating a consolidation phase.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
3

Positive Catalysts

  • Strong Q4 financial results with 32.46% YoY revenue growth and 369.32% YoY net income growth.

  • Hedge funds are significantly increasing their positions, with a 158.11% increase in buying activity.

  • Analysts maintain positive ratings with price targets ranging from $18 to $30, citing strong revenue growth, robust free cash flow, and durable margins.

Neutral/Negative Catalysts

  • Bearish moving averages indicate potential short-term weakness.

  • Lack of recent news or significant insider activity.

  • Concerns around AI displacement in the insurance tech sector, though analysts believe these fears are misplaced.

Financial Performance

EverQuote delivered record Q4 results in 2025, with revenue increasing to $195.32M (up 32.46% YoY), net income rising to $57.76M (up 369.32% YoY), and EPS growing to 1.54 (up 366.67% YoY). Gross margin also improved slightly to 97.73%. These results highlight the company's strong growth trajectory and profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are bullish on EverQuote, with multiple firms lowering price targets but maintaining Buy or Overweight ratings. JPMorgan, B. Riley, Needham, and Canaccord all highlight strong Q4 results, durable growth, and compelling value at current levels. Price targets range from $18 to $30, with a consensus that the stock is undervalued and offers significant upside potential.

Wall Street analysts forecast EVER stock price to rise
5 Analyst Rating
Wall Street analysts forecast EVER stock price to rise
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 15.660
sliders
Low
32
Averages
35
High
40
Current: 15.660
sliders
Low
32
Averages
35
High
40
JPMorgan
Cory Carpenter
Overweight
downgrade
$32 -> $22
AI Analysis
2026-02-24
Reason
JPMorgan
Cory Carpenter
Price Target
$32 -> $22
AI Analysis
2026-02-24
downgrade
Overweight
Reason
JPMorgan analyst Cory Carpenter lowered the firm's price target on EverQuote to $22 from $32 and keeps an Overweight rating on the shares. The company beat its outlook "across the board and delivered record seasonal growth," the analyst tells investors in a research note. The firm cites the Q4 upside to the ramping of new marketing channels and a strong finish to the year with EverQuote's largest carrier partners. JPMorgan believes the shares offer "compelling value" at current levels.
B. Riley
Buy
downgrade
$36 -> $30
2026-02-24
Reason
B. Riley
Price Target
$36 -> $30
2026-02-24
downgrade
Buy
Reason
B. Riley lowered the firm's price target on EverQuote to $30 from $36 and keeps a Buy rating on the shares. EverQuote reported "strong" Q4 results, with revenue and adjusted EBITDA exceeding guidance and consensus, with upside driven by strong auto insurance performance, the analyst tells investors in a research note. Risk/reward heavily skews to the positive considering EverQuote's durable growth, sustained margin expansion, robust free cash flow generation, pristine balance sheet, and the seemingly misplaced fears around AI disruption, the firm says.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EVER
Unlock Now

People Also Watch